comparemela.com
  1. Home
  2. Live Updates
  3. Lianhong Xu - Breaking News

Lianhong Xu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders

/PRNewswire/ Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient.

Lianhong xuBrii bioBrii biosciences limited bioBrii biosciences limited

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.